Cytogenetics and molecular genetics of cancer of the prostate
- PMID: 12407695
- DOI: 10.1002/ajmg.10694
Cytogenetics and molecular genetics of cancer of the prostate
Abstract
Prostate cancer remains the most common male malignancy in Western countries and the second-leading cause of death from cancer in males. Progress in the understanding of molecular and genetic mechanisms leading to this disease has only recently begun to offer a glimpse of the genes, chromosomal sites, and proteins implicated in the development and progression of prostate tumors. This brief review addresses some of the key issues in prostate cancer research, including a discussion of both hereditary and sporadic cancers as well as specific genes and chromosomal loci that likely play a part in the etiology of this disease.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
-
Molecular genetics of prostate cancer.Ann Chir Gynaecol. 1999;88(1):11-6. Ann Chir Gynaecol. 1999. PMID: 10230676
-
Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study.Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):417-8. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11927504 No abstract available.
-
Molecular pathology of prostate cancer.Pathol Int. 2005 Sep;55(9):531-9. doi: 10.1111/j.1440-1827.2005.01865.x. Pathol Int. 2005. PMID: 16143027 Review.
-
Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.Cancer Res. 2006 Nov 15;66(22):11077-83. doi: 10.1158/0008-5472.CAN-06-3024. Cancer Res. 2006. PMID: 17108148
-
The complex genetic epidemiology of prostate cancer.Hum Mol Genet. 2004 Apr 1;13 Spec No 1:R103-21. doi: 10.1093/hmg/ddh072. Epub 2004 Jan 28. Hum Mol Genet. 2004. PMID: 14749351 Review.
Cited by
-
Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers.J Clin Pathol. 2007 Nov;60(11):1238-43. doi: 10.1136/jcp.2006.043810. Epub 2007 Jan 26. J Clin Pathol. 2007. PMID: 17259299 Free PMC article.
-
Genetic alteration and gene expression modulation during cancer progression.Mol Cancer. 2004 Mar 22;3:9. doi: 10.1186/1476-4598-3-9. Mol Cancer. 2004. PMID: 15035667 Free PMC article. Review.
-
Upregulation of Cyclin B1 by miRNA and its implications in cancer.Nucleic Acids Res. 2012 Feb;40(4):1695-707. doi: 10.1093/nar/gkr934. Epub 2011 Nov 3. Nucleic Acids Res. 2012. PMID: 22053081 Free PMC article.
-
Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.Adv Cancer Res. 2015;127:49-121. doi: 10.1016/bs.acr.2015.04.006. Epub 2015 May 23. Adv Cancer Res. 2015. PMID: 26093898 Free PMC article. Review.
-
Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.Am J Pathol. 2011 May;178(5):2367-76. doi: 10.1016/j.ajpath.2011.01.050. Am J Pathol. 2011. PMID: 21514447 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical